Skip to main content

Table 3 The relationship of the ratio of etelcalcetide per session to oral cinacalcet per day with clinical factors

From: Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial

  45 patients 90 patients
  Exp (estimate) p value Exp (estimate) p value
Age 1.02 0.919 1.08 0.642
Sex 1.01 0.199 1.01 0.071
Duration of dialysis 0.74 0.147 0.81 0.221
spKt/V 0.54 0.087 0.58 < 0.05
cCa 1.00 0.989 0.96 0.779
P 1.01 0.904 0.97 0.642
iPTH 1.00 0.909 1.00 0.674
  1. 45 patients with intact PTH levels within the management target at screening and at the end of the study and with constant vitamin D agent and calcium-based phosphate binder doses